Torrent Pharmaceuticals Limited — Others, 28-07-2025: Shareholders meeting

Torrent Pharmaceuticals' 52nd Annual General Meeting approved its annual financial results for FY25. Shareholders confirmed an interim dividend of ₹ 26.00 and declared a final dividend of ₹ 6.00 per share. Key approvals included the re-appointment and appointment of Aman Mehta as Managing Director with remuneration, and ratification of cost auditors. The company also received approval for issuing equity shares, enhancing internal investment limits, creating charge on assets, and significantly increasing its borrowing limit from ₹ 15,000 Cr to ₹ 26,000 Cr, boosting financial flexibility for future growth.